World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2016
Main ID:  ISRCTN15823943
Date of registration: 13/05/2015
Prospective Registration: No
Primary sponsor: Hospital of Padova Neurology Clinic (Clinica Neurologica - Azienda Ospedaliera di Padova)
Public title: Repetitive transcranial magnetic stimulation (rTMS) in cocaine abusers
Scientific title: Pilot study on reducing the craving for a group of COCAine-dependent patients treated with repetitive transcranial magnetic stimulation (rTMS)
Date of first enrolment: 01/08/2014
Target sample size: 32
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN15823943
Study type:  Interventional
Study design:  Between-subject open-label randomised clinical trial (Treatment)  
Phase: 
Countries of recruitment
Italy
Contacts
Name: Luigi    Gallimberti
Address:  Piazza Castello 16 35141 Padova Italy
Telephone: +39 (0)392 9247378
Email: studio@studiogallimberti.it
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Diagnosis of current cocaine use disorder (CUD) based on the DSM-5
2. Seeking treatment for cocaine use

Exclusion criteria: 1. Pregnancy
2. Lifetime DSM-5 diagnosis of schizophrenia, bipolar disorder, psychosis or other psychiatric disorders
3. Diagnosis of current alcohol and/or substance use disorder (except for cocaine and smoking) based on the DSM-5
4. Diagnosis of epilepsy/seizure
5. Presence of devices, e.g. pace-makers, cochlear prosthesis, neuro-stimulators, magnetic cochlear prosthesis, intraocular metallic fragments


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Cocaine use disorder (CUD)
Mental and Behavioural Disorders
Mental and behavioural disorders due to use of cocaine: dependence syndrome
Intervention(s)
1. Group 1 (intervention group) will be treated with rTMS (MagVenture MagPro 30 model, B-70 Cool coil). The standards used for the stimulation were the following: 15 Hz frequency, impulse intensity equal to 100% of the rMT, 60 impulses per stimulation train, intertrain pause of 15 seconds, 40 stimulation trains, 2400 total impulses for a total duration of 13 minutes.
2. Group 2 (control group) will be treated with a standard protocol used for many years at the Department of Neurology where the study was conducted in Padua, Italy. This protocol includes pharmacological treatment with pramipexole 0.35 mg t.i.d., bupropione 150 mg daily, oxazepam 15 mg t.i.d., triazolam 0.25 mg daily and gamma hydroxybutyrate 1.75 gram daily.
Primary Outcome(s)
Use of cocaine assessed by either positive or negative urine drug screen test for cocaine compared in the rTMS versus control groups.
Secondary Outcome(s)
Craving for cocaine using a 0-10 Visual Analogue Scale.
Secondary ID(s)
3165/AO/14
Source(s) of Monetary Support
Hospital of Padova Neurology Clinic (Clinica Neurologica - Azienda Ospedaliera di Padova) (Italy), Novella Fronda Foundation - ONLUS (Italy)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history